That's one that I think we, and perhaps some of the other partners around the table, would need to think about. I know we only have a limited amount of capacity. If CDR were to all of a sudden really speed up, then we'd have to take a decision about trying to put more resources at the departmental level to evaluate that against our own drug plans.
I don't know if others have a view.